Novel biologic approaches for the treatment of AIDS

[1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958

[2] AMBRUS JL, 1989, AM J MED, V87, P405, DOI 10.1016/S0002-9343(89)80822-8

[3] BELSHE RB, 1984, TXB HUMAN VIROLOGY

[4] A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) : 1917 - 1927

[5] Chemokines and HIV-1 second receptors: The therapeutic connection [J]. NATURE MEDICINE, 1998, 4 (05) : 563 - 568

[6] IMMUNOGENICITY OF COMBINED ANTI-HIV AND ANTISUPPRESSIVE VACCINE PREPARATIONS [J]. BIOMEDICINE & PHARMACOTHERAPY, 1992, 46 (04) : 149 - 153

[7] Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy [J]. NATURE MEDICINE, 1997, 3 (10) : 1110 - 1116

[8] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J]. CELL, 1996, 85 (07) : 1135 - 1148

[9] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J]. SCIENCE, 1995, 270 (5243) : 1811 - 1815

[10] HIV-Specific cellular and humoral immune responses in primary HIV infection [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (12) : 1129 - 1140

[1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958

[2] AMBRUS JL, 1989, AM J MED, V87, P405, DOI 10.1016/S0002-9343(89)80822-8

[3] BELSHE RB, 1984, TXB HUMAN VIROLOGY

[4] A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) : 1917 - 1927

[5] Chemokines and HIV-1 second receptors: The therapeutic connection [J]. NATURE MEDICINE, 1998, 4 (05) : 563 - 568

[6] IMMUNOGENICITY OF COMBINED ANTI-HIV AND ANTISUPPRESSIVE VACCINE PREPARATIONS [J]. BIOMEDICINE & PHARMACOTHERAPY, 1992, 46 (04) : 149 - 153

[7] Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy [J]. NATURE MEDICINE, 1997, 3 (10) : 1110 - 1116

[8] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J]. CELL, 1996, 85 (07) : 1135 - 1148

[9] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J]. SCIENCE, 1995, 270 (5243) : 1811 - 1815

[10] HIV-Specific cellular and humoral immune responses in primary HIV infection [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (12) : 1129 - 1140